CognitiveIntramuscular

Cerebrolysin

Also known as: FPF-1070 · Cerebro

Porcine brain-derived peptide preparation containing neurotrophic peptides and amino acids. Mimics endogenous neurotrophic factor activity (BDNF, NGF) and promotes neuronal repair in stroke and dementia trials.

At a glance

Half-life: 24 hours
Common route: Intramuscular
Typical dose range: 5,000–30,000mcg
Stability (reconstituted): 1days refrigerated

Best timing

Typically administered in 10–20 day courses, daily IM or IV. Not a chronic-use peptide.

Contraindications

Status epilepticus or active seizure disorder
Severe renal impairment
Pregnancy
Known allergy to porcine proteins

Watch symptoms

Injection site burning or pain
Sweating, hot flushes
Headache during early doses
Rare hypersensitivity reactions
Mild fatigue or agitation

Citations

The primary literature.

01Cerebrolysin in Alzheimer's disease: a systematic review and meta-analysisPubMed
02Cerebrolysin for acute ischaemic stroke (Cochrane review)PubMed

Back to library